Addiction: Part I. Benzodiazepines - Side effects, abuse risk and alternatives

American Family Physician

Volumn 61, Issue 7, 2000, Pages 2121-2128

  Longo, Lance P ^a   Johnson, Brian ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPRAZOLAM; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CHLORDIAZEPOXIDE; CLONAZEPAM; CLORAZEPATE; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; DOXEPIN; FLURAZEPAM; HYPNOTIC AGENT; LORAZEPAM; METHADONE; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; OPIATE DERIVATIVE; OXAZEPAM; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; TRAZODONE; TRIAZOLAM; ZOLPIDEM TARTRATE;

AMNESIA; ANXIETY NEUROSIS; BEHAVIOR DISORDER; CONVULSION; DEPRESSION; DRUG ALCOHOL INTERACTION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG COMPETITION; DRUG DEPENDENCE; DRUG HALF LIFE; DRUG POTENCY; DRUG SAFETY; DRUG TOLERANCE; FETOTOXICITY; HUMAN; INSOMNIA; INTOXICATION; MOTOR DYSFUNCTION; MUSCLE SPASM; PSYCHOMOTOR RETARDATION; REVIEW; WITHDRAWAL SYNDROME;

ANTI-ANXIETY AGENTS; BENZODIAZEPINES; HALF-LIFE; HUMANS; RISK; SUBSTANCE-RELATED DISORDERS;

EID: 0034175682     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Salzman C, for Task Force on Benzodiazepine Dependency, American Psychiatric Association. Benzodiazepine dependence, toxicity, and abuse: a task force report of the American Psychiatric Association. Washington, D.C.: American Psychiatric Association, 1990.
2. American Druggist. Top 200 drugs of 1995. New York, N.Y.: Hearst Corp, 1996:18-26.
3. Hollister LE, Muller-Oerlinghausen B, Rickels K, Shader RI. Clinical uses of benzodiazepines. J Clin Psychopharmacol 1993;13(suppl 1):1S-169S.
4. Ciraulo DA, Sands BF, Shader RI. Critical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry 1988;145:1501-6.
5. Busto UE, Romach MK, Sellers EM. Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence. J Clin Psychopharmacol 1996;16:51-7.
6. Arana GW, Hyman SE. Handbook of psychiatric drug therapy. 2d ed. Boston: Little, Brown, 1991: 128-61.
7. Miller LG. Chronic benzodiazepine administration: from the patient to the gene. J Clin Pharmacol 1991;31:492-5.
8. Ashton H. Toxicity and adverse consequences of benzodiazepine use. Psychiatric Annals 1995;25:158-65.
9. Janicak PG, Davis JM, Preskhorn SH, Ayd FJ. Principles and practice of psychopharmacotherapy. Baltimore: Williams & Wilkins 1993:287.
10. Geene DS, Dockens RC, Salazar DE, et al. Coadministration of nefazadone and benzodiazepines. I. pharmacokinetic assessment [Abstract]. Clin Pharmacol Ther 1994;55:141.
11. Lader M. Long-term benzodiazepine use and psychological functioning. In: Freeman HL, Rue Y, eds. The benzodiazepines in current clinical practice. International congress and symposium series: proceedings of a symposium sponsored by Wyeth Laboratories. London: Royal Society of Medicine Services, 1987:55-69.
12. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DC, et al. Association of roadtraffic accidents with benzodiazepine use. Lancet 1998;352:1331-6.
13. Curran V. Memory functions, alertness, and mood of long-term benzodiazepine users: a preliminary investigation of the effects of normal daily dose. J Psychopharmacol 1992;6:69-75.
14. van der Bijl P, Roelofse JA. Disinhibitory reactions to benzodiazepines: a review. J Oral Maxillofac Surg 1991;49:519-23.
15. Smith BD, Salzman C. Do benzodiazepines cause depression? Hosp Comm Psychiatry 1991;42: 1101-2.
16. Bergman U, Rosa FW, Baum C, Wiholm BE, Faich GA. Effects of exposure to benzodiazepines during fetal life. Lancet 1992;340:694-7.
17. Kales A, Scharf MB, Kales JD. Rebound insomnia: a new clinical syndrome. Science 1978;201:1039-41.
18. Schneider-Helmert D. Why low-dose benzodiazepine-dependent insomniacs can't escape their sleeping pills. Acta Psychiatr Scand 1988;78:706-11.
19. Mellinger GD, Baiter MB, Uhlenhuth EH. Prevalence and correlates of the long-term use of anxiolytics. JAMA 1984;251:375-9.
20. Marriott S, Tyrer P. Benzodiazepine dependence. Avoidance and withdrawal. Drug Saf 1993;9:93-103.
21. Busto U, Sellars EM, Naranjo CA, Cappell H, Sanchez-Craig M, Sykora K. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med 1986;315:854-9.
22. Ashton H. Protracted withdrawal syndromes from benzodiazepines. J Subst Abuse Treat 1991;8:19-28.
23. Herings RM, Stricker BH, de Boer A, Bakker A, Sturmans F. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med 1995; 55:1801-7.
24. Hemmelgarn B, Suissa S, Huang A, Boivin IF, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 1997;278:27-31.
25. Salzman C, Fisher J, Nobelk, Glassman R, Wolfson A, Kelly M. Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Geriatr Psychiatry 1992;7:89-93.
26. Burke KC, Meek WJ, Krych R, Nisbett R, et al. Medical services use by patients before and after detoxification from benzodiazepine dependence. Psychiatric Services 1995;46(2):157-60.
27. Gold MS, Miller NS, Stennie K, Populla-Vardi C. Epidemology of benzodiazepine use and dependence. Psychiatric Annals 1995;25:146-8.
28. Dumont RL. Abuse of benzodiazepines - the problems and the solutions. A report of a Committee of the Institute for Behavior and Health, Inc. Am J Drug Alcohol Abuse 1988;14(suppl 1):1-69.
29. Iguchi MY, Griffiths RR, Bickel WK, et al. Relative abuse liability of benzodiazepines in methadone-maintained populations in three cities. In: Harris LS, ed. Problems of drug dependence, 1988: proceedings of the 50th Annual Scientific Meeting, the Committee on Problems of Drug Dependence, Inc. Rockville, Md.: U.S. Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse, Office of Science, 1989. DHHS publication no. (ADM) 89-1605.
30. Roache JD, Meisch RA. Findings from self-administration research on the addiction potential of benzodiazepines. Psychiatric Annals 1995;25(3):153-7.
31. Parran TV. Prescription drug abuse. A question of balance. Med Clin North Am 1997;81:967-78.
32. Longo LP. Non-benzodiazepine pharmacotherapy of anxiety and panic in substance abusing patients. Psychiatric Annals 1998;28(3):142-53.
33. Longo LP, Johnson B. Treatment of insomnia in substance abusing patients. Psychiatric Annals 1998; 28(3):154-9.
34. Zolpidem for insomnia. Med Lett Drugs Ther 1993; 35:35-6.